These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3569381)

  • 1. Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction.
    Bergogne-Bérézin E; Muller-Serieys C; Joly-Guillou ML; Dronne N
    Eur Urol; 1987; 13 Suppl 1():64-8. PubMed ID: 3569381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fosfomycin-trometamol (monuril): pharmacokinetics and food-drug interactions].
    Muller-Serieys C; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):753-6. PubMed ID: 3309810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of fosfomycin trometamol (Monuril).
    Segre G; Bianchi E; Cataldi A; Zannini G
    Eur Urol; 1987; 13 Suppl 1():56-63. PubMed ID: 3569380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity.
    Bergan T
    Infection; 1990; 18 Suppl 2():S65-9. PubMed ID: 2286464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal.
    Borgia M; Longo A; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):411-7. PubMed ID: 2793277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of fosfomycin trometamol.
    Bergan T; Thorsteinsson SB; Albini E
    Chemotherapy; 1993; 39(5):297-301. PubMed ID: 8370321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections.
    de Jong Z; Pontonnier F; Plante P
    Urol Int; 1991; 46(4):344-8. PubMed ID: 1926651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
    Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
    Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
    Bergan T
    Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trometamol salt of fosfomycin (Monuril). Preliminary pharmacokinetic and clinical experience in the treatment of urinary tract infections in children.
    Careddu P; Borzani M; Varotto F; Garlaschi L; Fontana P
    Eur Urol; 1987; 13 Suppl 1():114-8. PubMed ID: 3552695
    [No Abstract]   [Full Text] [Related]  

  • 11. Fosfomycin trometamol: historical background and clinical development.
    Gialdroni Grassi G
    Infection; 1990; 18 Suppl 2():S57-9. PubMed ID: 2286462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers.
    Wijma RA; Koch BCP; van Gelder T; Mouton JW
    Clin Microbiol Infect; 2018 May; 24(5):528-532. PubMed ID: 28867662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
    Dubini F; Riviera L
    Chemioterapia; 1988 Feb; 7(1):15-9. PubMed ID: 3259909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria.
    Neuman M; Rufin F
    Eur Urol; 1987; 13 Suppl 1():105-7. PubMed ID: 3552693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration.
    Aramayona JJ; Bregante MA; Solans C; Rueda S; Fraile LJ; Garcia MA
    Vet Res; 1997; 28(6):581-8. PubMed ID: 9428152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of fosfomycin and its bioavailability.
    Cadórniga R; Diaz Fierros M; Olay T
    Chemotherapy; 1977; 23 Suppl 1():159-74. PubMed ID: 832511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies.
    Kuemmerle HP; Murakawa T; Sakamoto H; Sato N; Konishi T; De Santis F
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):521-8. PubMed ID: 4066076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin kinetics after intravenous and oral administration to human volunteers.
    Goto M; Sugiyama M; Nakajima S; Yamashina H
    Antimicrob Agents Chemother; 1981 Sep; 20(3):393-7. PubMed ID: 7305325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monuril in lower uncomplicated urinary tract infections in adults.
    Moroni M
    Eur Urol; 1987; 13 Suppl 1():101-4. PubMed ID: 3552692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies on absorption, distribution and excretion of fosfomycin. I. Absorption distribution and excretion of fosfomycin calcium salt (author's transl)].
    Fujita M; Tomono N; Abe M; Hosoi K; Sato T
    Jpn J Antibiot; 1975 Jun; 28(3):309-13. PubMed ID: 1152284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.